SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Craig-Hallum Initiates Coverage On Strongbridge Biopharma with Buy Rating, Announces $7.5 Price Target

Craig-Hallum analyst Francois Brisebois initiates coverage on Strongbridge Biopharma (NASDAQ:SBBP) with a Buy rating and a $7.5 price target.

Benzinga · 03/03/2020 13:10

Craig-Hallum analyst Francois Brisebois initiates coverage on Strongbridge Biopharma (NASDAQ:SBBP) with a Buy rating and a $7.5 price target.